Single intravenous doses of placebo

DRUG2 trials

Sponsors

MicuRx, Recida Therapeutics, Inc.

Conditions

Safety

Phase 1

Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4

CompletedNCT03033329

Start: 2016-10-31End: 2018-03-31Updated: 2018-03-22

Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01

TerminatedNCT03832517

Recida Therapeutics, Inc.Safety

Start: 2019-04-14End: 2019-05-08Updated: 2019-05-29